Patients with cataracts exhibit notable increases in the expression levels of interleukin-6 (IL-6), IL − 1β, and tumor necrosis factor-α (TNF-α) compared to healthy individuals (Dong et al., 2019). This evidence concerns the gene IL6 and cataract.